文献速递生殖医学

体外受精实验室中SARS-CoV-2感染风险的评估与管理

Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory.
PubMed 文献 · Reprod Biomed Online · 2020-06-27

本研究由多学科体外受精(IVF)团队开展失效模式与效应分析(FMEA),评估COVID-19应急期间IVF实验室中气溶胶介导病毒感染的风险。除细胞间污染被认为极不可能外,患者-员工、员工-员工及员工-细胞交互的失效模式被评估为中度至高度感染风险;主要纠正措施包括预防性后勤措施、增加个人防护装备及调整实验室流程与日程。作者认为标准实验室方案不足以应对气溶胶传播的病毒。

要点

  • 采用失效模式与效应分析(FMEA)评估IVF实验室气溶胶介导病毒感染风险。
  • 除细胞间污染被认为极不可能外,其余交互失效模式为中度至高度感染风险。
  • 纠正措施包括预防性后勤措施、增加个人防护装备及调整实验室流程与日程。

核心结论

  • 标准实验室方案不足以应对气溶胶传播的病毒,本FMEA提出的措施不仅应用于当前大流行,也应在未来用于及时管理任何气溶胶介导的病毒感染。

研究设计与样本

  • 由多学科IVF团队开展失效模式与效应分析(FMEA),制定COVID-19应急期间的新方案与流程示意图。
  • 分析应急各阶段的潜在失效模式并聚焦可能的错误来源,风险优先数按发生度×严重度×检出度计算。

主要发现

  • 除细胞间污染被认为极不可能外,患者-员工、员工-员工及员工-细胞交互的失效模式被评估为中度至高度感染风险。
  • 主要纠正措施包括预防性后勤措施、增加个人防护装备、调整IVF实验室流程及日常作息安排。
  • 部分流程亦经修订,以提高员工的意识与谨慎程度。

临床怎么用

  • 作者认为标准实验室方案不足以应对气溶胶传播的病毒。
  • 作者认为本FMEA提出的措施不仅应用于当前大流行,也应在未来用于及时管理任何气溶胶介导的病毒感染。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The study set out to identify corrective measures aimed at reducing the risk of aerosol-mediated viral infection within an IVF laboratory. DESIGN: A failure modes and effect analysis (FMEA) was conducted by a multidisciplinary IVF team. A schematic representation of new protocols and procedures adopted during COVID-19 emergency has been defined, including directives about the behaviour to adopt when entering the clinic and the laboratory, in case of face-to-face contact with patients and between staff members. In addition, the risk of cross-contamination between samples belonging to different patients during cell handling and manipulation has been evaluated. Potential failure modes for each phase of the emergency have been analysed, focusing on possible sources of error. Risk priority numbers have been calculated as products of Occurrence × Severity × Detection scores. RESULTS: Except for cell-cell contamination, which was considered highly unlikely, failure modes during patient-staff, staff-staff and staff-cell interactions were estimated as carrrying a moderate to high risk of infection. The main corrective measures entailed precautionary logistic measures, the implementation of additional personal protective equipment and changes in the IVF laboratory procedures and scheduling of the daily routine. Some procedures were also revised, aiming to increase staff's awareness and caution. CONCLUSIONS: Standard laboratory protocols are insufficient to face a virus whose transmission is aerosol mediated. The measures outlined in this FMEA should thus be considered not only for facing this pandemic, but also for the future to promptly manage any aerosol-mediated virus infection, whose impact on the management of an IVF laboratory might be less severe than COVID-19 although not completely negligible.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Maggiulli R, Giancani A, Fabozzi G, et al. Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory. Reprod Biomed Online. 2020. PMID: 32693991. doi:10.1016/j.rbmo.2020.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。